一般的な便中病原体の分子診断検査
Molecular diagnostic testing for common stool pathogens
G. Trafford*, N. Ratnaraja, N. Wickramasinghe
*Heart of England Foundation Trust, UK
Journal of Hospital Infection (2015) 90, 196-198
No abstract.
サマリー原文(英語)はこちら
監訳者コメント:
便中の腸管病原体の検出に、日常的な検査として遺伝子検査が用いられるケースはこれまで少なかった。しかしながら、従来法は感度や手間、費用などの点で制約が大きかったのも事実である。本稿は、PCR 法を用いる長所、ピットフォール、結果の解釈、コスト比較など、実用化と感染対策への応用に向けた課題について述べている。
同カテゴリの記事
Does nosocomial COVID-19 result in increased 30-day mortality? A multi-centre observational study to identify risk factors for worse outcomes in patients with COVID-19
K.S. Khan*, H. Reed-Embleton, J. Lewis, J. Saldanha, S. Mahmud
*University Hospital Hairmyres, UK
Journal of Hospital Infection (2021) 107, 91-94
Qualitative study of the factors impacting antimicrobial stewardship programme delivery in regional and remote hospitals
Higher arterial catheter-related infection rates in femoral than in dorsalis pedis access
Hospital outbreak of New Delhi metallo-β-lactamase type-1 (NDM-1) in Salmonella enterica with interspecies plasmid transmission A.G. Beukers*, M.A. John, R. Davis, A. Lee, S.J. van Hal *Royal Prince Alfred Hospital, Australia Journal of Hospital Infection (2021) 117, 23-27
Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong
S.C.Y. Wong*, R.T-S. Kwong, T.C. Wu, J.W.M. Chan, M.Y. Chu, S.Y. Lee, H.Y. Wong, D.C. Lung
*Queen Elizabeth Hospital, Hong Kong Special Administrative Region
Journal of Hospital Infection (2020) 105, 119-127
